Is Franklin Genomic Advancements ETF halal to invest in?

As of September 2026, Franklin Genomic Advancements ETF HELX is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Franklin Genomic Advancements ETF a Shariah-compliant ETF?

An ETF is considered Shariah-compliant if its underlying assets consist primarily of companies that operate in permissible business activities and meet Islamic financial screening thresholds. Musaffa analyzes Franklin Genomic Advancements ETF using these criteria to determine its compliance status.

How often is the Shariah compliance for Franklin Genomic Advancements ETF updated?

The Shariah compliance status of Franklin Genomic Advancements ETF may be updated periodically when new portfolio disclosures, financial statements of underlying companies, or other relevant information becomes available.

Can a halal ETF like Franklin Genomic Advancements ETF become non-compliant?

Yes. An ETF that is currently Shariah-compliant may become non-compliant if its underlying holdings change or if the financial ratios of the companies within the fund exceed Shariah thresholds.

Where can I check the Shariah status of Franklin Genomic Advancements ETF?

You can check the latest Shariah compliance status of Franklin Genomic Advancements ETF on Musaffa's ETF page, where screening results and key indicators are updated to help Muslim investors make informed decisions.

Franklin Genomic Advancements ETF HELX

HELX Shariah Compliance

Screening Methodology: AAOIFI

As of September 2026, Franklin Genomic Advancements ETF is classified as halal.

HALAL

Is Franklin Genomic Advancements ETF Halal?

Shariah Compliance Analysis of HELX ETF

US Equity Theme

Yes. As of September 2026, Franklin Genomic Advancements ETF (HELX) is classified as HALAL by Musaffa under its AAOIFI-based Shariah screening methodology. Franklin Genomic Advancements ETF passes Musaffa's business and financial screening criteria.

HELX was created on 2020-02-25 by Franklin. The fund's investment portfolio concentrates primarily on theme equity. HELX is an actively managed portfolio of global equity securities of companies relevant to genomic discovery.

Franklin Genomic Advancements ETF (HELX) Chart

Key Statistics of Franklin Genomic Advancements ETF (HELX)

Today's Open

AUM

Avg. Volume

Expense Ratio

P/E Ratio

P/B Ratio

Sector Exposure

Health Care
88.40%
Other
6.77%
Information Technology
2.31%
Materials
2.21%
Real Estate
0.31%

FAQ's for Franklin Genomic Advancements ETF (HELX)

As of September 2026, Franklin Genomic Advancements ETF HELX is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
An ETF is considered Shariah-compliant if its underlying assets consist primarily of companies that operate in permissible business activities and meet Islamic financial screening thresholds. Musaffa analyzes Franklin Genomic Advancements ETF using these criteria to determine its compliance status.
The Shariah compliance status of Franklin Genomic Advancements ETF may be updated periodically when new portfolio disclosures, financial statements of underlying companies, or other relevant information becomes available.
Yes. An ETF that is currently Shariah-compliant may become non-compliant if its underlying holdings change or if the financial ratios of the companies within the fund exceed Shariah thresholds.
You can check the latest Shariah compliance status of Franklin Genomic Advancements ETF on Musaffa’s ETF page, where screening results and key indicators are updated to help Muslim investors make informed decisions.